| 发明名称 | Controlled release levetiracetam formulations and methods for producing the same | ||
| 摘要 | Pharmaceutical compositions in the form of tablets are disclosed including water-soluble active ingredients such as levetiracetam and a polymer component which primarily includes water-insoluble polymers comprising between 60% and 100% of the polymer component in the tablet core, preferably the entire polymer component in the tablet core. The pharmaceutical compositions can also include an extended-release coating including both water-soluble and water-insoluble polymers. | ||
| 申请公布号 | US9333175(B2) | 申请公布日期 | 2016.05.10 |
| 申请号 | US201012816620 | 申请日期 | 2010.06.16 |
| 申请人 | Mylan Inc. | 发明人 | Murty Mummini Aruna;Li Boyong |
| 分类号 | A61K9/20;A61K9/22;A61K9/28;A61K31/4015 | 主分类号 | A61K9/20 |
| 代理机构 | Lerner David Littenberg Krumholz & Mentlik | 代理人 | Lerner David Littenberg Krumholz & Mentlik |
| 主权项 | 1. A pharmaceutical composition in the form of a tablet comprising a compressed tablet core comprising a water-soluble active ingredient comprising levetiracetam and a polymer component consisting essentially of a water-insoluble polymer comprising from between about 1 and 50 wt. % of said compressed tablet core, and comprising substantially the only polymer in said compressed tablet core, such that said compressed tablet core is free of any water-soluble polymer. | ||
| 地址 | Canonsburg PA US | ||